{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE306nnn/GSE306364/"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Mus musculus"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306364"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Comprehensive Analysis of Type 2 Innate Lymphoid Cells Heterogeneity and Identification of CD81 as a Marker for Pathogenic IL-13⁺ ILC2s in Atopic Dermatitis Skin","description":"CD81 is a novel surface marker of pathogenic ILC2s, enriched in IL-13⁺/IL-5⁺ subsets in atopic dermatitis. Using scRNA-seq on IL18Tg and KCASP1Tg mice, and human AD skin before and after Dupilumab, we demonstrate that CD81 marks type 2 cytokine–producing ILC2s conserved across species","dates":{"publication":"2026/08/30"},"accession":"GSE306364","cross_references":{"GSM":["GSM9197935","GSM9197936"],"GPL":["24247"],"GSE":["306364"],"taxon":["Mus musculus"]}}